Literature DB >> 11062205

Susceptibility of Cryptococcus neoformans by the NCCLS microdilution and Etest methods using five defined media.

M A Petrou1, D C Shanson.   

Abstract

The susceptibility of 12 isolates of Cryptococcus neoformans to amphotericin B, 5-fluorocytosine, fluconazole, itraconazole and ketoconazole was tested using the NCCLS and Etest methods with yeast nitrogen base (YNB) pH 5.6 and pH 7.0, RPMI MOPS pH 7.0 with and without added glucose (2%) and RPMI buffered with phosphate buffer to pH 7.0. Some isolates yielded poor growth in RPMI MOPS after 72 h. Tests indicated that YNB pH 5.6 was the best medium for 5-fluorocytosine but was unsuitable for ketoconazole. In conclusion, YNB pH 7.0 or RPMI MOPS with 2% glucose can be used with either method.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11062205     DOI: 10.1093/jac/46.5.815

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  9 in total

1.  A non-polyene antifungal antibiotic from Streptomyces albidoflavus PU 23.

Authors:  S K Augustine; S P Bhavsar; B P Kapadnis
Journal:  J Biosci       Date:  2005-03       Impact factor: 1.826

2.  Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates obtained through population-based surveillance in South Africa in 2002-2003 and 2007-2008.

Authors:  Nelesh P Govender; Jaymati Patel; Marelize van Wyk; Tom M Chiller; Shawn R Lockhart
Journal:  Antimicrob Agents Chemother       Date:  2011-03-28       Impact factor: 5.191

Review 3.  Combination treatment of invasive fungal infections.

Authors:  Pranab K Mukherjee; Daniel J Sheehan; Christopher A Hitchcock; Mahmoud A Ghannoum
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

4.  Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds.

Authors:  Calliandra Maria de-Souza-Silva; Fernanda Guilhelmelli; Daniel Zamith-Miranda; Marco Antônio de Oliveira; Joshua Daniel Nosanchuk; Ildinete Silva-Pereira; Patrícia Albuquerque
Journal:  J Vis Exp       Date:  2018-02-14       Impact factor: 1.355

5.  Evaluation of Etest method for determining voriconazole and amphotericin B MICs for 162 clinical isolates of Cryptococcus neoformans.

Authors:  M J Maxwell; S A Messer; R J Hollis; D J Diekema; M A Pfaller
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

6.  Binding of serum mannan binding lectin to a cell integrity-defective Cryptococcus neoformans ccr4Delta mutant.

Authors:  John C Panepinto; Kazimierz W Komperda; Moshe Hacham; Soowan Shin; Xiaoguang Liu; Peter R Williamson
Journal:  Infect Immun       Date:  2007-07-23       Impact factor: 3.441

7.  Overexpression of TUF1 restores respiratory growth and fluconazole sensitivity to a Cryptococcus neoformans vad1Delta mutant.

Authors:  John C Panepinto; Amanda L Misener; Brian G Oliver; Guowu Hu; Yoon Dong Park; Soowan Shin; Theodore C White; Peter R Williamson
Journal:  Microbiology (Reading)       Date:  2010-04-29       Impact factor: 2.777

8.  Penicillium species as a rare isolate in tracheal granulation tissue: a case series.

Authors:  Premjit S Randhawa; Sa Reza Nouraei; David J Howard; Gurpreet S Sandhu; Michael A Petrou
Journal:  J Med Case Rep       Date:  2008-03-17

9.  Exploration of Antifungal and Immunomodulatory Potentials of a Furanone Derivative to Rescue Disseminated Cryptococosis in Mice.

Authors:  Sudarshan Singh Rathore; Muthukrishnan Isravel; Sridharan Vellaisamy; David Raj Chellappan; Lalitha Cheepurupalli; Thiagarajan Raman; Jayapradha Ramakrishnan
Journal:  Sci Rep       Date:  2017-11-13       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.